Copeland Capital Management LLC Has $27.38 Million Stock Holdings in iRadimed Corporation $IRMD

Copeland Capital Management LLC decreased its stake in iRadimed Corporation (NASDAQ:IRMD) by 6.7% in the 2nd quarter, HoldingsChannel reports. The institutional investor owned 457,919 shares of the medical equipment provider’s stock after selling 32,625 shares during the period. Copeland Capital Management LLC’s holdings in iRadimed were worth $27,379,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Vanguard Group Inc. lifted its holdings in iRadimed by 3.3% in the first quarter. Vanguard Group Inc. now owns 554,451 shares of the medical equipment provider’s stock valued at $29,098,000 after buying an additional 17,640 shares during the period. Goldman Sachs Group Inc. lifted its stake in shares of iRadimed by 1.1% in the 1st quarter. Goldman Sachs Group Inc. now owns 169,387 shares of the medical equipment provider’s stock valued at $8,889,000 after purchasing an additional 1,821 shares during the period. Acadian Asset Management LLC lifted its stake in shares of iRadimed by 10.9% in the 1st quarter. Acadian Asset Management LLC now owns 156,319 shares of the medical equipment provider’s stock valued at $8,197,000 after purchasing an additional 15,329 shares during the period. Bank of New York Mellon Corp boosted its position in shares of iRadimed by 1.6% during the 1st quarter. Bank of New York Mellon Corp now owns 101,665 shares of the medical equipment provider’s stock valued at $5,335,000 after purchasing an additional 1,557 shares in the last quarter. Finally, Envestnet Asset Management Inc. boosted its position in shares of iRadimed by 20.3% during the 1st quarter. Envestnet Asset Management Inc. now owns 70,473 shares of the medical equipment provider’s stock valued at $3,698,000 after purchasing an additional 11,892 shares in the last quarter. Institutional investors and hedge funds own 92.34% of the company’s stock.

Insider Activity at iRadimed

In related news, Director Monty K. Allen sold 1,102 shares of the firm’s stock in a transaction that occurred on Wednesday, August 6th. The stock was sold at an average price of $69.10, for a total transaction of $76,148.20. Following the completion of the sale, the director owned 19,898 shares of the company’s stock, valued at $1,374,951.80. This trade represents a 5.25% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, CEO Roger E. Susi sold 5,000 shares of the firm’s stock in a transaction that occurred on Wednesday, October 1st. The stock was sold at an average price of $70.19, for a total value of $350,950.00. Following the sale, the chief executive officer directly owned 2,347,500 shares of the company’s stock, valued at $164,771,025. This represents a 0.21% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 16,102 shares of company stock valued at $1,139,748 in the last ninety days. 36.80% of the stock is currently owned by insiders.

iRadimed Price Performance

NASDAQ IRMD opened at $71.08 on Friday. The business has a 50 day simple moving average of $69.70 and a 200 day simple moving average of $60.18. iRadimed Corporation has a one year low of $46.86 and a one year high of $74.43. The stock has a market capitalization of $904.14 million, a P/E ratio of 43.88 and a beta of 1.02.

iRadimed Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Thursday, August 28th. Investors of record on Monday, August 18th were paid a dividend of $0.17 per share. The ex-dividend date of this dividend was Monday, August 18th. This represents a $0.68 annualized dividend and a yield of 1.0%. iRadimed’s dividend payout ratio (DPR) is currently 41.98%.

iRadimed Profile

IRadimed Corp. engages in the development, manufacture, marketing, and distribution of Magnetic Resonance Imaging compatible medical devices. It also provides a non-magnetic Intravenous infusion pump system that is specifically designed for use during MRI procedures. The company was founded by Roger Susi in July 1992 and is headquartered in Winter Springs, FL.